Can Fulgent Genetics Inc. (FLGT) Remain Competitive?

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Fulgent Genetics Inc. (NASDAQ:FLGT) went down by -3.65% from its latest closing price compared to the recent 1-year high of $189.89. The company’s stock price has collected -5.23% of loss in the last five trading sessions. The Wall Street Journal reported on 04/05/21 that The Pandemic Year’s Top Stock-Fund Managers

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Fulgent Genetics Inc. (NASDAQ :FLGT) Right Now?

Fulgent Genetics Inc. (NASDAQ:FLGT) scored a price-to-earnings ratio above its average ratio, recording 11.08 x from its present earnings ratio. Plus, the 36-month beta value for FLGT is at 1.62. Opinions of the stock are interesting as 2 analysts out of 4 who provided ratings for Fulgent Genetics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


The average price from analysts is $107.00, which is -$3.07 below the current price. FLGT currently public float of 14.29M and currently shorts hold a 32.09% ratio of that float. Today, the average trading volume of FLGT was 2.07M shares.

FLGT’s Market Performance

FLGT stocks went down by -5.23% for the week, with a monthly jump of 0.79% and a quarterly performance of 56.95%, while its annual performance rate touched 875.58%. The volatility ratio for the week stands at 7.32% while the volatility levels for the past 30 days are set at 11.65% for Fulgent Genetics Inc.. The simple moving average for the period of the last 20 days is -9.11% for FLGT stocks with a simple moving average of 64.43% for the last 200 days.

Analysts’ Opinion of FLGT

Many brokerage firms have already submitted their reports for FLGT stocks, with Credit Suisse repeating the rating for FLGT by listing it as a “Underperform.” The predicted price for FLGT in the upcoming period, according to Credit Suisse is $40 based on the research report published on January 08th of the current year 2021.

Oppenheimer gave a rating of “Outperform” to FLGT, setting the target price at $75 in the report published on August 20th of the previous year.

FLGT Trading at -17.14% from the 50-Day Moving Average

After a stumble in the market that brought FLGT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.99% of loss for the given period.

Volatility was left at 11.65%, however, over the last 30 days, the volatility rate increased by 7.32%, as shares sank -1.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +34.42% upper at present.

During the last 5 trading sessions, FLGT fell by -5.23%, which changed the moving average for the period of 200-days by +456.64% in comparison to the 20-day moving average, which settled at $102.32. In addition, Fulgent Genetics Inc. saw 78.64% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at FLGT starting from Xie Jian, who sale 3,000 shares at the price of $104.10 back on Mar 15. After this action, Xie Jian now owns 342,476 shares of Fulgent Genetics Inc., valued at $312,300 using the latest closing price.

Xie Jian, the Chief Operating Officer of Fulgent Genetics Inc., sale 62,000 shares at $102.65 during a trade that took place back on Mar 09, which means that Xie Jian is holding 345,476 shares at $6,364,219 based on the most recent closing price.

Stock Fundamentals for FLGT

Current profitability levels for the company are sitting at:

  • +68.80 for the present operating margin
  • +78.70 for the gross margin

The net margin for Fulgent Genetics Inc. stands at +51.85. The total capital return value is set at 86.52, while invested capital returns managed to touch 66.77. Equity return is now at value 92.70, with 75.70 for asset returns.

Based on Fulgent Genetics Inc. (FLGT), the company’s capital structure generated 2.78 points at debt to equity in total, while total debt to capital is 2.71. Total debt to assets is 2.25, with long-term debt to equity ratio resting at 0.10. Finally, the long-term debt to capital ratio is 0.10.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 2.30, with the company’s debt to enterprise value settled at 0.02. The receivables turnover for the company is 3.99 and the total asset turnover is 1.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.02.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.